article · PLoS neglected tropical diseases
INTRODUCTION: Chikungunya is an arboviral disease characterized by acute osteoarticular manifestations with a risk of progression to chronicity. African data on post-chikungunya chronic arthralgia are scarce. This study aimed to identify factors associated with post-chikungunya chronic arthralgia in Burkina Faso. PATIENTS AND METHODS: This was a descriptive and analytical cross-sectional study with ambispective data collection, conducted from April 22 to December 28, 2024, at the Medical Center of Pouytenga. All patients aged 16 years and older with RT-PCR- confirmed chikungunya virus infection were included. The evaluation comprised an initial clinical phase and telephone follow-up at 6 months of evolution. RESULTS: We enrolled 174 patients, of whom 111 met the inclusion criteria. The mean age was 31.18 years ± 11.27 years with a female predominance of 66.67% (n = 74). Initial osteoarticular manifestations affected 92.79% of patients (n = 103), predominantly inflammatory arthralgia in 92.23% (n = 95) and symmetric polyarticular involvement in 73.79% (n = 76). At 6 months of evolution, 28.16% (n = 29) of patients had post-chikungunya chronic arthralgia, with persistence in the ankles in 65.52% of cases (n = 19). Multivariate analysis identified two significantly associated risk factors for chronic arthralgia were age greater than 31 years (OR = 6.22; 95% CI [2.35-16.47]; p < 0.001) and dengue coinfection (OR = 18.67; 95% CI [1.74-199.70]; p = 0.016]; p = 0.024). CONCLUSION: Our study found that 28.16% of patients develop post-chikungunya chronic arthralgia at 6 months post infection. Age above 31 years was demonstrated to be a significant predictor of disease chronicity, while the potential role of dengue co-infection, observed in only 4 patients with wide confidence intervals, requires further investigation.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1371/journal.pntd.0014251
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.